CAJAL NEUROSCIENCE
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
CAJAL NEUROSCIENCE
Industry:
Biotechnology Pharmaceutical
Founded:
2020-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.cajalneuro.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Amazon Google Apps For Business Google DNS
Current Employees Featured
Founder
Investors List
Lux Capital
Lux Capital investment in Seed Round - Cajal Neuroscience
Official Site Inspections
http://www.cajalneuro.com Semrush global rank: 3.75 M Semrush visits lastest month: 3.6 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cajal Neuroscience"
Cajal Neuroscience - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number 7814377402; Cajal Neuroscience is a biotechnology company integrating human genetics, functional genomics, and advanced …See details»
Team — Cajal Neuroscience
Cajal is building a research and development team with the passion, drive, and scientific expertise to execute its bold mission of generating novel disease-altering therapies for neurodegeneration.See details»
Cajal Neuroscience - LinkedIn
Cajal Neuroscience Biotechnology Research Seattle, WA 4,327 followers Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.See details»
Science — Cajal Neuroscience
Our approach is to build a platform for target discovery and validation, one of unprecedented scope and depth that not only allows us to “see” what is happening in the degenerating brain, but also where and when.Accomplishing …See details»
Cajal Neuroscience - PitchBook
Cajal Neuroscience General Information Description. Developer of disease-altering therapies intended for the treatment of neurodegenerative diseases. The company develops viral tools and platforms to screen for the targets with …See details»
Cajal Neuroscience Launches with $96 Million to …
Nov 29, 2022 Inspired by the pioneering work of Santiago Ramón y Cajal, whose discoveries on the structural and functional organization of the brain became the foundation of modern neuroscience, Cajal seeks ...See details»
Cajal Neuroscience - VentureRadar
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease. ... Find out more about Cajal Neuroscience, biotech, healthcare, gene, Neurodegenerative disease, …See details»
Seattle startup with fresh approach to Parkinson’s and …
Nov 29, 2022 Microscopy image of neurons in the mouse brain. (Cajal Neuroscience Image) Cajal Neuroscience, a Seattle startup taking a unique approach to developing treatments for neurodegenerative diseases ...See details»
Cajal launches with $96m for neurodegeneration drug discovery
Dec 1, 2022 Cajal Neuroscience, a biotechnology company integrating human genetics, functional genomics and advanced microscopy to discover novel targets and therapeutics for …See details»
Cajal Neuroscience - Work in biotech
Cajal Neuroscience is developing drugs for neurodegenerative diseases. The complexity of the brain was uncovered by pioneering research by Santiago Ramón y Cajal, who illustrated his …See details»
Cajal launches with $96M to advance therapeutics for ... - Healio
Nov 30, 2022 Biotechnology company Cajal Neuroscience announced its launch with $96 million Series A financing with plans to combine human genetics, functional genomics and advanced …See details»
Cajal Neuroscience Launches with $96 Million to Transform Target …
Inspired by the pioneering work of Santiago Ramón y Cajal, whose discoveries on the structural and functional organization of the brain became the foundation of modern neuroscience, Cajal …See details»
Cajal will tackle neurodegeneration | C&EN Global Enterprise
Dec 5, 2022 Cajal Neuroscience has launched with $96 million in series A financing to find targets and therapeutics for neurodegeneration. The Seattle-based company says it aims to …See details»
Cajal Neuro and Creyon Bio join forces on neurodegeneration
May 9, 2024 US biotechnology companies Cajal Neuroscience and Creyon Bio have formed a strategic partnership aimed at developing oligonucleotide-based medicines to combat …See details»
Cajal and the Spanish Neurological School: Neuroscience Would …
May 24, 2019 Santiago Ramón y Cajal was still young when he came across the reazione nera, discovered by the Italian Camillo Golgi.Cajal became absolutely entranced by the fine …See details»
Creyon Bio and Cajal Neuroscience Announce Partnership to
May 1, 2024 SAN DIEGO and RESEARCH TRIANGLE PARK, N.C. and SEATTLE, May 01, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. (See details»
Cajal Neuroscience and Creyon Bio Announce Partnership to …
SEATTLE, SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., May 1, 2024 -- Cajal Neuroscience, ("Cajal"), a biotechnology company integrating disease-focused genetics and …See details»
Cajal bodies in neurons - PubMed
Sep 16, 2016 Cajal is commonly regarded as the father of modern neuroscience in recognition of his fundamental work on the structure of the nervous system. But Cajal also made seminal …See details»
News — Cajal Neuroscience
Nov 29, 2022 Cajal Neuroscience and Creyon Bio Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases. May 01, 2024See details»